Brain Cancer Science Talk

Postcards from the Field

Some green shoots of investing progress as MissionGBM welcomes its 300th case

Jul 30 •

Scott L. Rakestraw, PhD

Michael Lim, MD – Brain Cancer Science Talk (Episode 7)

Stanford’s Chair of Neurosurgery discusses the promise and challenges associated with immunotherapy for brain tumors

Jul 15 •

Scott L. Rakestraw, PhD

30:07

David D. Tran, MD, PhD – Brain Cancer Science Talk (Episode 6)

An Open-Minded and Curious Physician/Scientist Follows the #Data to Innovate a Compelling Protocol for Treating Gliomas

Jun 5 •

Scott L. Rakestraw, PhD

58:11

Paul S. Mischel, MD – Brain Cancer Science Talk (Episode 5)

ecDNA, the Importance of Science, #Data and Collaboration, and Upgrading Science in Neuro-Oncology

May 30 •

Scott L. Rakestraw, PhD

43:30

Samuel Blackman, MD, PhD – Brain Cancer Science Talk (Episode 4)

Physician, Scientist, Entrepreneur…and Humanitarian

May 15 •

Scott L. Rakestraw, PhD

36:15

John de Groot, MD – Brain Cancer Science Talk (Episode 3)

Immunotherapy, Combination Protocols, Focused Ultrasound and Emerging Technologies for Treating Brain Tumors with Some Thoughts About Improvements to…

May 7 •

Scott L. Rakestraw, PhD

26:04

Graeme Woodworth, MD – Brain Cancer Science Talk (Episode 2)

Neurosurgical Techniques to Treat Brain Cancers and Enhance Transport of Therapeutic Agents Across the Blood Brain Barrier

May 3 •

Scott L. Rakestraw, PhD

34:34

Michael L. Dougan, MD, PhD – Brain Cancer Science Talk (Episode 1)

Understanding and Managing Immune-Related Adverse Events in Immuno-Oncology Protocols

May 2 •

Scott L. Rakestraw, PhD

32:14

Coming Soon: Brain Cancer Science Talk Series

Leading brain cancer scientists and physicians discuss their state-of-the-art research with MissionGBM

May 1 •

Scott L. Rakestraw, PhD

CAR-Ts and GBM: A Long Way Yet to Go

Are you ready for a N-valent CAR-T (N>4) with concomitant checkpoint inhibition…and the (S)AEs that come with it…to be available in perhaps 10 years?

Mar 15 •

Scott L. Rakestraw, PhD

Immuno-Oncology: A Question of Balance

A SARS-CoV-2 infection precipitates a cascading series of immunological adverse events

Apr 15, 2023 •

Scott L. Rakestraw, PhD

Results That Matter

Team Julie delivers a remarkable outcome based on leading edge clinical science

Feb 2, 2023 •

Scott L. Rakestraw, PhD

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts